KIN实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 08:00):

Stats
今日成交量	178 496
平均成交量	1.51M
市值	0.00
EPS	$-0.200 ( 2021-08-05 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.09
ATR14	$0.0820 (0.89%)

Insider Trading

Date	Person	Action	Amount	type
2021-08-27	Park West Asset Management Llc	Sell	6 000 002	Common Stock, par value $0.0001 per share
2021-08-27	Wee Wendy	Sell	78 613	Common Stock
2021-08-27	Wee Wendy	Sell	32 500	Stock Option (right to buy)
2021-08-27	Wee Wendy	Sell	10 000	Stock Option (right to buy)
2021-08-27	Wee Wendy	Sell	75 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 100 transactions
Buy: 510 888 \| Sell: 9 693 361

音量相关性

長: 0.19 (neutral)

短: -0.40 (neutral)

Signal:(69.694) Neutral

Kindred Biosciences, Inc. 相关性

10 最正相关
KRTX	0.986
FOCS	0.971
XM	0.963
BRAC	0.963
CRVL	0.961
MLVF	0.961
MDGL	0.96
ALGM	0.96
THRX	0.959
ACLS	0.958

10 最负相关
PIII	-0.973
PDBC	-0.973
UTME	-0.973
CYXT	-0.972
BIOL	-0.965
IMKTA	-0.962
MRBK	-0.958
SMFL	-0.958
SOLO	-0.956
CYAN	-0.952

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Kindred Biosciences, Inc. 相关性 - 货币/商品

0.45
( neutral )

0.73
( moderate )

-0.17
( neutral )

0.30
( neutral )

0.28
( neutral )

-0.71
( moderate negative )

Kindred Biosciences, Inc. 财务报表

Annual	2020
营收:	$42.16M
毛利润:	$37.54M (89.03 %)
EPS:	$-0.550

FY	2020
营收:	$42.16M
毛利润:	$37.54M (89.03 %)
EPS:	$-0.550

FY	2019
营收:	$4.26M
毛利润:	$3.67M (86.21 %)
EPS:	$-1.590

FY	2018
营收:	$1.97M
毛利润:	$1.64M (83.52 %)
EPS:	$-1.600

Financial Reports:

No articles found.

Kindred Biosciences, Inc.

Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.